2025-07-02
REL
PDBe
INITIAL_RELEASE
REPOSITORY
INITIAL_RELEASE
REPOSITORY
EXPERIMENTAL_SUMMARY
em_admin
em_software
- _em_admin.last_update
- _em_software.name
DATABASE_REFERENCES
chem_comp_atom
chem_comp_bond
citation
citation_author
DATABASE_REFERENCES
citation
citation_author
- _citation.journal_volume
- _citation.page_first
- _citation.page_last
- _citation_author.identifier_ORCID
STRUCTURE_SUMMARY
em_admin
em_software
pdbx_entry_details
- _em_admin.last_update
- _em_software.name
- _pdbx_entry_details.has_protein_modification
PDBe
PDBe
2022-05-17
2023-05-31
2023-05-31
2025-07-02
Agence Nationale de la Recherche (ANR)
ANR-17-CE12-0022
France
NuA4 Histone Acetyltransferase Complex (Composite)
Schultz P
Ben-Shem A
Frechard A
Papai G
Smirnova E
Faux C
Lo Ying Ping F
Helmlinger D
Schultz P
Ben-shem A
NuA4, histone acetyltransferase complex, Epigenetics, DNA repair, TRANSCRIPTION
Frechard A
Faux C
Hexnerova R
Crucifix C
Papai G
Smirnova E
McKeon C
Ping FLY
Helmlinger D
Schultz P
Ben-Shem A
The structure of the NuA4-Tip60 complex reveals the mechanism and importance of long-range chromatin modification.
Nat.Struct.Mol.Biol.
US
30
1337
1345
2023
37550452
doi:10.1038/s41594-023-01056-x
1545-9985
Schultz P
Frechard A
Hexnerova R
Crucifix C
Papai G
Smirnova E
Faux C
Ping F
Helmlinger D
Ben-Shem A
The structure of the NuA4/Tip60 complex reveals the mechanism and importance of long-range chromatin modification
Res Sq
US
2022
doi:10.21203/rs.3.rs-1497616/v1
2693-5015
EMD-14980
other EM volume
Lower resolution raw consensus map
EMD-15066
other EM volume
Focused Refinement
EMD-15067
other EM volume
Focused Refinement
EMD-15070
other EM volume
Focused Refinement
7zvw
FULLOVERLAP
NuA4 histone acetyltransferase complex
NuA4 histone acetyltransferase complex
0
1
2
3
4
5
6
Komagataella phaffii GS115
Transcription-associated protein
Komagataella phaffii GS115
GS115 / ATCC 20864
0.43805534399999996
1
LEVO
MLHVVQLDDFATRLKAAEDYQSKHSVLSEICDSLETFNAAQDYEYFLKSLIPLFIDVLKEVPVSFVANSPENKLRNITLE
ILHRIPANDALQAYSNEIVDTLMDLLKVENELNGILCMKAITTLHKTFKASLQEKVHPFIDIVIEIYSNIPQVVEEQFNG
NQIDSKENVDSTSRPNSPSFSSQSDDSKQLAQAMFSFKTLAESPITMVSLYSSYKELAASSLGNFIPHVMKVLSLEVAKQ
AEARKAAEEKGIILVNVCKEITNRANYGEFIIGQVKAASFLAYLFIRRQAQTFLEPYQQAIPDIIIRLLQDCPSELSAAR
KELLHATRHILSTDFRKMFIPKIDLLFDLRVLIGEGFTAYETLRPLAYSTVADFIHNVRDHLTPAQLWKSVSIYCKNLQD
DSLALTVQIMSAKLLLNLIEKIMRSESKTESRQLLMVIIDAYTKRFKMLNSRYNGIMKQHATYEKEKQEKQNQERLLTNK
LDGTTPSPSDDKKVELIDEDQDVKMEDPTPEISDQETIKGDNDASTEPQDSEQQLADFMSLQEYLPIQVSVPPEIDLLKD
SRYLFKTLMTFLKTIMIGLKNSNPPSSQNHFNAQNWNETARGFSNEDINILKSLFRECILALRFFSTSKTSLPASSMKQS
FDITGPNLPITSTKEEKDLMEIFATMFIHIDPASFNEIVREELPFMYKQMLDFASLLHIPQFFLASVITSSSFSGILITF
LKSKLVDLGEVNIIKSNILIRLFKLCFMSVSLFPAANESVILPHLNELILKSLKLSTTAKEPLVYFYLIRTLFRSIGGGR
FENLYKEIMPLLQVLLESLSKLIHEARRPQERDIYVELCLTVPVRLSVLVPHLSYLMKPLVYALNGSQESVSQGLRTLEL
CVDNLTAEYFDPIIEPVIDDVMEALSKHLKPLPYYHQHSHTTLRILGKLGGRNRTFIKPVDNLKTDSELFQNVEAMFKIH
GLPNEVPLSITPGLSAAFSLLTDPRPRIHYRINSFKYISGIFQLFLGATQLPDDYANRLKESMDIILEDTIAPDEPLNKL
HHFPVKDIAKYDSQMELLVKLLESIFYAVSLQEVREESKALIRGTCNHFILLYFNKMVIDKRKFVRKFSVDNHEGNLFLN
ENCIFDAIIYALSSDNSAVRSMGLESVQLIYDSCVELFGNIDCALKFAPLNVMCSKFIHCCFEEPYHKKLAGCIGLEMML
NSLDIPMKYFNARQLEIIRALFYVLRDTAPELPCEVTNTAKRLILNSLKEWNKELTRNDVFSSVFQNLVSSLIVDLPNAN
EIVRATAQEALRTLSETTQVPIATMISPCKHILLAPIFGKPLRALPFQMQIGNIDAITFCMGLENSFLEYNEELNRLVQE
ALALVDAEDESLVSAHRISEHKTSEQLVRLRVVCIQLLSLAITKPEFAAAQQRSNIRVKILVVFFKSLCGRSIEIIRAAH
GGLKAVIDLKMKLPKELLQNGLRPMLMNLSDHKKLTVASLEALSGLLKLFISYFKVGIGSKLLDHLLAWAQPRTLQQLGS
QDLENNSTVQIIVAILDVFHLLPPTAHKFMNDLMNALLYLENNLHRCQYSPFREPLAKFLDRFPDESFEYFFNEFSKREI
TTRFVYFVGLDSCSSLRAKVLESLPRVRGLLHQEGSAEEKCVRFSNLVDLCESLAASDKEWIKDKEELLGELLDAGSVCL
TLKRSSNVVSPLYFQVDQGFETLQLLYIEYFKSQPLGHEKVFNFIDKISKEGLPFVLEFDDFIFNEVVKCQDIPTVQQTL
DTIIRMTPQVSSLDARVYLYKRIFLPICIYESEMHGDLSRLSQTENNELPAWLKSFDSDVWKATGPLVDDYTSTLEDRYR
LELMQLTALLIKGAPTALTDMRKDIIKFSWNYIKLDDNTSKQAAYVVTAYFISRFDTPSELTTRIFVALLRCHQIDTRYL
VKQALELLAPVLSERTNSELDWLKWPRRVLSEDGFNITQVANIYQLIVKFPDLFYPARDHFIPNIITAMGKLTVMSNTSL
ENQQLAIDLAELILKWETKLPKSEKLGSAEETEKEKSVSEDKMDIDVKEETKEDIAERPKAEDQIGGDDSDSSNILTSED
YEVSFAQREACVTFLIRYICISTQRPSENELGKRALNILYELLGPKYWSEVTVKLQFFERFLMSSDLNQPSLLGYCLNAL
EVLAVALKWKPTTWIIENVSYLQKLLEKCLRSDNQDIQEILQKVLGIILEAINKETQGSEEDEPEEVTNFISLIVNIIGE
DLSNMTSVAAGVSLCWTLSLYRPNALDSLLPSIMRTFNKLCRDHIAISLQGNQPQSGDFANIEFEAKVTTNLLEKILNLC
AARISSLDDQRRVFLSLLAQLIDRSVDKDMLLKVINIVTEWIFKTDFYPTTKEKAGILGKMMIFDLRGEPELSKKFNQVI
VDIFESKELAHTELTARMETAFLFGTRLSDVSIRKKLMSILSDSLELDIDKRLFYIIKDQNWEYLSDYPWLNQALQLLYG
SFHLDSPIRLSPEENTLSPLQSITEGLAREKSPVEKAPQNIIDFVAKHNEFLDSVRSLTAGDILNPLIDISYQSAETIHN
AWVVVFPVAYSAIESRYELEFTRALVKLLFKDYHIRQQDARPNVIKSLLDGVGKCPGLHLPPHLVKYLGSNYNAWYGAIK
LLEELSEGQGIDNQKISDANQDALLEVYMSLQEDDMFYGTWRRRAKYFETNAALSYEQIGIWDKALQLYEAAQIKARSGV
FPFGESEYSLWEDHWIYCAEKLQHWEILTELAKHEGFTDLLLECGWRGADWIADREPLEQSVKTVMDIPTPRRQIFQTFL
ALQGFSQQKDTLQDVSRLCDEGIQLTLRKWNALPQRVTRAHIGLLHTFQQYVELMEASQVYSSLVTTNAQNLDVKSQELK
RVLQAWRERLPNVWDDINIWNDLVTWRQHVFGVINRVYMPFVPVLQQSNGTNNGNSYAYRGYHEMAWVINRFAHVARKHE
MPEVCINQLTKIYTLPNIEIQEAFLKLREQAKCHYQNSSELNTGLDVISNTNLVYFATQQKAEFFTLKGMFLAKLNAKDE
ANQAFATAVQIDLNLPKAWAEWGFFNDRRFKENPEEIFHAKNAISCYLQAAGLYKDGKTRKLLCRILWLISLDDAAGSLA
KTFEDHHGESPVWYWITFVPQLLTSLSHKEAKIVRHILIQIAKSYPQSLHFQLRTTKEDYQAIQRQAMAVNRAEEQSSNK
QDTADSVLKNTNTPQPQTRTETSGTTAESDKKPSIPPKEEQGSPQPSRPATTQASPQAQSQENGESSQKHPPEIPTTDSR
QPWQDVEEIMGILKTAYPLLALSLESLVDQLNQRFKCNADEDAYRLVIVLYNDGVQQMNRVANPREEVKLPAATEASISR
FADSVLPKNIREVFEQDIIACNPNLETYISKLRKWRDCLEEKLDRSYGKADLERVSLHLSLFHHQKFEDIEIPGQYLLHK
DNNNHFIKIERFLPTLDLVRGSNGCYKRMTIRGNDGSLHPFAVQFPAARHCRREERIFQLFRIFDDALSRKVQSRRRNIS
LTLPIAVPLSPHIRILNDDKRYTTLMGIYEEFCRRKGQSRDEPFAYTIQKLRAAFDPRLPKPDIVSVRAEVLASIQSTLV
PSTLLKDYYTEKFSNYENYWLFRKQFTAQYASFIFMTYIMCINSRQPQKIHINEGSGNIWTSEMLPTKVATGKTHSTAYN
NSTLDPAVKAGAPIFYNTESVPFRLTPNIQKFIGEAGLEGILSVYILVIANSLSDSEFDMEQYLSLFVRDEVISWFAQQH
RASAQTNQLREIVRVNVELLTKRVLQLNHIPNSQNVATQFVLNLISQAVNPRNLAYTDSAWMAYL
C4QYV4
Actin
Komagataella phaffii GS115
GS115 / ATCC 20864
0.041736406000000004
1
LEVO
MDGEDVAALVIDNGSGMCKAGYAGDDAPHTVFPSVVGRPRHQGVMVGMGQKDSFVGDEAQSKRGILTLRYPIEHGIVTNW
DDMEKIWHHTFYNELRLAPEEHPVLLTEAPMNPKSNREKMTQIMFETFNVPAFYVSIQAVLSLYASGRTTGIVLDSGDGV
THVVPIYAGFSLPHAILRIDLAGRDLTDYLMKILSERGYTFSTSAEREIVRDIKEKLCYVALDFDQELQTSSQSSSIEKS
YELPDGQVITIGNERFRAPEALFHPSVLGLEASGIDQTTYNSIMKCDVDVRKELYSNIVMSGGTTMFPGIAERMQKELTA
LAPSSMKVKISAPPERKYSVWIGGSILASLGTFQQMWISKQEYDESGPSIVHLKCF
Q9P4D1
Actin
Komagataella phaffii GS115
GS115 / ATCC 20864
0.053009073999999996
1
LEVO
MATAPQVYGADEINAVVLDASSYRTKIGYGSLDCPILNLPSYYGHQTKDGSEKFIFEENSMLIPRPDYEIKKIMKDGIID
DFEGAVKQYNYMFDVLKLKPSEQPILVIESTQNEYEKKTALLKQLLKENKFVATFLIKNPTCVSFAHGRPNCLVVDLGHD
LVTITPILDGISLRKQVLGTHYAGAFLSQQLRQLLNHKGVEVVPVYKVKSKVPTYFPDEAKFEERKYDFDISESFENFHK
LRILREMKETLLQALPDSETEKLKEQETEEDTRYFEFPNGLNVPFTKYERVRLANSLFNPSEPYTGESGPNIVVEGFSVE
TGKIINEDTITSREYVPLRRSKKTDSSSGRRSKDEPTDDKPRGLTSLVNQALNHLDVDLKPQLANNIILTGATSLIPGVA
ERLNQELTAMNPGLKVRIHSSANVIERTCSAWIGGSILSSLGTFHQLWVSENEYDEVGAKKLIMDRFR
C4QXM9
Chromatin modification-related protein EAF1
Komagataella phaffii GS115
GS115 / ATCC 20864
0.11849882
2
LEVO
MSSLDSNVTASSKHDSPKRQPEDGSGTNDDPLQRILNERKRKLAELYCVSRLPLLPISPSQVSQIGENLMRFLERNDLEQ
GRQFNITTLTGDKSQKQPPVSKEVSTADQLESPHWPVKEDEETTKDEPPRKKQKTASTSAEPQKATHKESKMTMMHQEVT
ESEAPTLSSLIRKYAQDEVPIRPDDPTDRDLNFELLDRNKTIIQALPEIYPHKIADSASLTELYYLTQTFPLAKLLPRSH
KSLTTDAYESALLEGKIAVLYSRIEELKRQRKWSLRQPKRFIDPFTRESPTHWDHLLAEMKWLSVDIMEERKFKAASCVQ
LAQAVSDYWTYGKIVCIQRKPLIFLTDEEIKERTVTKVMKTEVDNENEHDHDDNDIFKDAQEEPRAMDQEQNQPFEENAT
IDVAKLLERPNPKDEIIPPALPTYSMGDYKRLNQNAEPFKLHIGLDDFKKEDLVLVEKLPLSFIFDDNLSDSKKKLSEYE
KAPIAAISTLLAPPEDDEWYKIVIRRDPASELSASLDYQKGLFGASSQRRYNVLKPPKPPPIKNLELRTPTIWLPQDDKL
LIRYVAEYAFNWDIISAHLSARPARAYVANIERRTPWQCFERYIQLNDKFQFTDMRGQYAQSAQAWLEAAHKTQSTTKRR
ISPLGVGIESIQRGHRRLRWGSMLDAMRKCMRRRENINRSSQVERKHTSDDKRTNVPTPEELSRLKYDRDKAIQEAYMHQ
NSGTFSSARPHTQSSALSPSKGKNAPLPTSAQQTGTHPYTNGIPPKGTLPKTTTPAPGVPSTQPGTPNTRQPQVSSRVAT
SQNTTPVTNRTGTPNGNRPGPNNSFTQEQLQHFLQAQRHRQMMQTSAGTPVNKSNVPNRPAGITNTNVTTPANAVSSSTT
PSKSAATASQQQPSPSRGINLTPAQVNALINQIQAQNPNMSKDQVTKFAVAYIQNLQNQRERSSNGHSTPQVRTVPTPTR
ATAGPPVSASPVTSNASPTTPASLTKEKLDALENSPNLTPQQRQQITLFKAMQARNKMNQVANRGQESASASSNLSASPN
TDTKQTTDTNK
C4R7G0
SWR1-complex protein 4
Komagataella phaffii GS115
GS115 / ATCC 20864
0.06491641799999999
1
LEVO
MSSDILDVLSISGRSNLSNQKKKITKDGPTKKKKQTAMSRELFNLIGQNTPPLAVEKTVKFKEKLNVNNKPTPWSYVEFS
NDARESKDGLKLHHWIKGSSELAKNSPYLFEKYNQKIQIPSFTKEEYDEFLKDLDLECREREKRDKALKEQEAKEAEKLE
KEKENDKERVNGDELGKEEDNASDFVPKKENVNDQILPKIDEPQTNKKDDMESTEDVSKSDSQEVSKDVNPSEEVEASWD
YDETVHLFQLCEKWDLRWPIIVDRYEYDERSMEELKERFYKVSERILRHKYRNVTMDDKTSLLVQTLSSFDKRRETERKQ
YLRRLLSRSPTEIAEEESLVIEARKFELAAKKMLTERASLLRLLDSPQSTGSISQYLTSQGLTQLYNTLMSADRSKRRKV
ETPTPPQIPPGASSSLHRTSMDLKRKAAKKIGPNALLENIKATGNSVPPSGNAPQSAAIELINTKMTPEEKEAYGIKIHQ
EKLQPGVSLRSARLPTFKPATQAKIVVVLNELEVSPKPTIPTAKVVAQYDNLLQTINVLLETKKQVNKLEVELNLLEGKE
EDKES
C4R0G7
Enhancer of polycomb-like protein
Komagataella phaffii GS115
GS115 / ATCC 20864
0.086836922
1
LEVO
MVLPSAAGARFRQRKISVKQTLQVFKQSDIADLETEDQQRELQKIETGVEKGEEEEEHLQRVINAAQAAVISGGKVEKAY
IPTPDASQVWKDYDKYYRDKFQPPGTYIRFSATVEETTGCIYNLDEEDESFLKEVLNKNLANGIKPCTETELEIVLQRFE
VVIDKKQPFLAMDPSQILTFEELHSAALVVDPNSIEEIELSLEKQLGLHPFRTLLDGQRSQLSHRKLAELLRIFGQKIYD
HWKQRRIARHGRPITAQLRFEDSSEKDDSDPYVCFRRREFRQARKTRRTDTQGSERLRKLHRELKQTRDLLLAVAQREVK
RKEAIEVGHEVFQLRCSVKTLKRDLGVKGEEEDLVAHKRKKVVPTTDEDRKYRKGYNSGNYPNRNQAQAQQQQQQLQQQQ
ISKSGLNPVSIQPYVKLPMSRIPDMDLITVSTVLNEKDEAINRAVAEKLRQRKESDRGWVNLTDDPFNPFLQFTNPDSIL
EKGHFPYSSIAAALFEVDQSNYFDPEITQLIKDKKPLPRTLCFKDNALTTPLPPSIYEVASNNKLDVTAPICKVRKRMGR
RGLWIDRKMTVDEPLDEFLDFSTFEKSLDADITDRNSAKSQQGMNVYDSVDDANSRLRSRFSFDRDVPLFNPVDPSELNQ
ISSQTQSIRFGCMLLTKAYEQVHQAKQKLFLEQQQHQQKQQQKLLQQRQKVQQKLQQQQQQQQQAQQQNPKSNTNKVVNQ
INNTKSPVKQSKIPSKVSKNISGVTTSAGKGA
C4R6V1
ADENOSINE-5'-TRIPHOSPHATE
0.000507181
2
ATP
MAGNESIUM ION
2.4305e-05
2
MG
singleParticle
particle
0.25
8.0
20.0
HEPES
4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid
150.0
KOAc
Potassium acetate
5.0
MgOAc
Magnesium acetate
2.0
TCEP
tris(2-carboxyethyl)phosphine
5.0
NH4OAc
Ammonium acetate
0.0025
DDM
Dodecyl-maltoside
ETHANE
100
279
FEI VITROBOT MARK IV
TFS KRIOS
FLOOD BEAM
BRIGHT FIELD
FIELD EMISSION GUN
300
1.4000000000000001
3.8000000000000003
FEI TITAN KRIOS AUTOGRID HOLDER
NITROGEN
GIF Quantum LS
20
GATAN K3 (6k x 4k)
SUPER-RESOLUTION
52.8
1
1265830
cryoSPARC
PHASE FLIPPING AND AMPLITUDE CORRECTION
cryoSPARC ab-initio reconstruction
3.4
FSC 0.143 CUT-OFF
cryoSPARC
518386
MAXIMUM LIKELIHOOD
cryoSPARC
MAXIMUM LIKELIHOOD
cryoSPARC